Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

Hyde, C, Wake, B, Bryan, S, Barton, PM, Fry-Smith, A, Davenport, C and Song, F (2002) Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technology Assessment, 6 (2). pp. 1-89. ISSN 2046-4924

Full text not available from this repository. (Request a copy)
Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: EPrints Services
Date Deposited: 25 Nov 2010 11:10
Last Modified: 21 Apr 2020 20:47
URI: https://ueaeprints.uea.ac.uk/id/eprint/12946
DOI:

Actions (login required)

View Item View Item